Pharmafile Logo
Pharmafocus logo
Advanced Search

Does Trump pose a threat to the FDA’s future?

February 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Trump

President Trump’s first month in office made headlines across the industry just as it did in the wider media. Promises …

Feature
merckincweb1

MSD’s investigational cytomegalovirus treatment shows significant promise in Phase 3 trial

February 27, 2017
Research and Development, Sales and Marketing MSD, cytomegalovirus, letermovir

MSD has lifted the curtain on strong Phase 3 results in the development of its investigational antiviral drug letermovir, showing …

News
hand

Assay opens way to autoantibodies treatment for rheumatoid arthritis

February 27, 2017
Research and Development, Sales and Marketing rheumatoid arthritis

A new discovery, conducted by researchers at the NYU Langone Medical Center and the University of Pittsburgh, has pointed towards …

News
vaccine

Cuba begins Phase 1 testing of HIV vaccine

February 27, 2017
Research and Development, Sales and Marketing Cuba, HIV

Cuba has announced that it has begun testing a HIV vaccine that looks to reduce the ‘payload’ of the virus …

News
nathalie_moll

EFPIA names first female Director General

February 27, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EFPIA

Industry trade organisation the European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced the appointment of Nathalie Moll as …

Appointment

Weight loss drug reduces diabetes risk by 80%, according to ICL research

February 27, 2017
Research and Development, Sales and Marketing diabetes, icl, liraglutide

Researchers from Imperial College London have published research showing that use of weight loss drug liraglutide lowered the risk of …

News
celgene_1_02

Celgene announces shock departure of COO

February 27, 2017
Medical Communications, Sales and Marketing Celgene

Celgene released in a statement that its Chief Operating Officer and President, Jacqualyn “Jackie” Fouse, will retire from her position. …

News
astrazeneca-sign

AstraZeneca’s hyperkalaemia treatment rebounds with European recommendation

February 24, 2017
Sales and Marketing AstraZeneca, EMA

AstraZeneca have received some positive news on its hyperkalaemia drug, ZS-9, as it received a recommendation from the Committee for …

News
atul_pande

Ex-GSK SVP instated as CMO at PureTech

February 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PureTech Health

PureTech Health, a cross-disciplinary biopharmaceutical company, announced that it had appointed Atul Pande as the Chief Medical Officer. Pande had …

Appointment
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

February 24, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s Friday again, and this week in pharma has seen a slew of positive clinical trial results released in Crohn’s …

News
abpi_article

Developing talent and partnership to create new medicines

February 24, 2017
Medical Communications ABPI

The ABPI discusses how investing in R&D education and collaboration can reap long-term benefits to the pharmaceutical industry and the …

News
currency-166422_960_720

India’s NPPA identifies 634 non-compliant drug pricings

February 24, 2017
Medical Communications, Sales and Marketing Abbott, AstraZeneca, Cipla, Dr Reddy's, Dr Reddy’s, nppa

India’s National Pharmaceutical Pricing Authority (NPPA) has revealed that as many as 634 drugs from top pharma firms in the …

News
roche_close

Death in trial of Roche’s potential blockbuster haemophilia drug

February 24, 2017
Medical Communications, Research and Development Novo Nordisk, Roche, Shire, haemophilia

Roche has reported a death in the trial of its haemophilia treatment, emicizumab, that will only add to safety concerns …

News
nathalie_moll

EFPIA names new first female Director General Nathalie Moll

February 24, 2017
Business Services, Medical Communications, Sales and Marketing EFPIA, appointment

Industry trade organisation the European Federation of Pharmaceutical Industries and Associations (EFPIA) has announced the appointment of Nathalie Moll as …

News
cognition_kit

Takeda collaborates to launch wearable-tech depression study

February 23, 2017
Medical Communications, Research and Development Takeda, depression, mental health, wearable tech

Takeda and Cognition Kit Limited have announced a collaborative venture to trial the use of an app in the monitoring …

News
2000px-bristol-myers_squibb_logo

BMS temporarily expands Board with three new additions

February 23, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb

Bristol-Myers Squibb has bolstered its Board of Directors with the appointment of three Directors, a move which temporarily expands its …

Appointment
the-chinese-national-flag-1752046_960_720

China’s insurance expansion boon to global pharma

February 23, 2017
Sales and Marketing AstraZeneca, China, GSK, Shire

China has expanded the list of medicines that are covered on basic medical insurance schemes, named China’s National Reimbursement Drug …

News
egypt_india_locator

Sun Pharma inaugurates first Egypt production facility

February 23, 2017
Manufacturing and Production, Sales and Marketing Egypt, India, Ranbaxy, Sun Pharma

Ranbaxy, a subsidiary of India’s Sun Pharma, has opened its first production facility in Egypt in a bid to further …

News
celltrion

First biosimilar for European cancer treatment given approval

February 23, 2017
Sales and Marketing biosimilar, celltrion

The first biosimilar will be made available in Europe to match the indications of Roche’s best-selling cancer drug, Rituxan. The …

News

Novartis’ Zykadia scores priority review and breakthrough designation from FDA

February 23, 2017
Sales and Marketing Novartis, zykadia

Novartis’ lung cancer treatment Zykadia (ceritinib) has been awarded both priority review and breakthrough therapy designation by the US Food …

News
The Gateway to Local Adoption Series

Latest content

Stage4You encourages stage 4 bowel cancer patients to prioritise mental health ahead of Bowel Cancer Awareness Month

March 26, 2026

Scotland starts newborn screening for SMA

March 26, 2026

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026